SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market

SynAct Pharma AB (8F8) Balance Sheet

0 Followers

SynAct Pharma AB Balance Sheet

SynAct Pharma AB's total assets for Q were kr142.60M, an increase of 48.22% from the previous quarter. DE:8F8 total liabilities were kr16.08M for the fiscal quarter, a -0.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
kr 142.60Mkr 38.37Mkr 21.59Mkr 25.91Mkr 13.26M
Total Liabilities
kr 16.08Mkr 17.50Mkr 5.72Mkr 13.73Mkr 3.72M
Total Equity Gross Minority
kr 126.52Mkr 20.87Mkr 15.87Mkr 12.19Mkr 9.54M
Total Capitalization
kr 126.52Mkr 20.87Mkr 15.87Mkr 12.19Mkr 9.54M
Preferred Stock Equity
-----
Capital Lease Obligations
kr 2.06Mkr 3.09Mkr 0.00--
Currency in SEK

SynAct Pharma AB Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis